Results 61 to 70 of about 252 (105)

Case Report: Use of MLC601 in Severe Traumatic Brain Injury

Neurosurgery - Cases and Reviews, 2022
Kumar Ramesh, Shawn Peh Hong, Venketasubramanian Narayanaswamy   +2 more
openaire   +1 more source

The Efficacy of NeuroAid™ (MLC601) in Modulating NF-κB Expression and Improving Outcomes in Traumatic Brain Injury: A Preclinical Study

Bioscientia Medicina : Journal of Biomedicine and Translational Research
Background: Traumatic brain injury (TBI) represents a significant global health concern, leading to substantial mortality and long-term disability. The intricate pathophysiology of TBI involves primary mechanical damage followed by a cascade of secondary injury events, including neuroinflammation, apoptosis, and oxidative stress.
null Dedy Chandra Hariyono, null Hanis Setyono, null Ida Bagus Budhi Surya Adnyana   +2 more
openaire   +1 more source

Supplementary Material for: Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study

, 2020
Background: Most comparative clinical trials are designed to assess the treatment effect for efficacy endpoints, with less emphasis on the analysis of safety outcomes.
Chen C.L.H. (8523633), Lu Q. (4105666), Moorakonda R.B. (8523630), On behalf of the CHIMES Investigators (8523636), Venketasubramanian N. (2878934)   +4 more
core   +1 more source

Interventions for visual field defects after stroke: a systematic review. [PDF]

, 2017
Etter et hjerneslag er det mange som mister deler av synsfeltet. Det er vanlig å miste halvparten av synsfeltet (høyre eller venstre) på begge øynene. Tiltak som har blitt forsøkt er å gjenvinne hele eller deler av synsfeltet (restitusjon), kompensere ...
Myrhaug, Hilde Tinderholt, Smedslund, Geir   +1 more
core  

Ischemic Stroke: New Insights from Risk Factors, Mechanisms and Outcomes. [PDF]

J Cardiovasc Dev Dis, 2023
Venketasubramanian N.
europepmc   +1 more source

MLC901 in hypoxic-ischemic brain injury patients: A double-blind, randomized placebo-controlled pilot study. [PDF]

Medicine (Baltimore), 2023
Pakdaman H, Gharagozli K, Karamiani F, Shamsi Goushki M, Moini S, Sobhanian A, Maghsoudlu F, Esfandani A, Hosseini MH, Amini Harandi A.   +9 more
europepmc   +1 more source

Spinal cord injury - assessing tolerability and use of combined rehabilitation and NeuroAiD (SATURN) study - primary results of an exploratory study. [PDF]

J Spinal Cord Med, 2023
Kumar R, Htwe O, Baharudin A, Rhani SA, Ibrahim K, Nanra JS, Gsangaya M, Harun H, Kandar K, Balan M, Peh S, Pokharkar Y, Ingole A, Hisam Ariffin M.   +13 more
europepmc   +1 more source

Additional file 1 of Cost-effectiveness of MLC601 in post-stroke functional recovery compared with placebo - the CHIMES & CHIMES-E studies

Supplementary Material 1.
Chen, Christopher Li Hsian, Chai, Jia Hui, Pokharkar, Yogesh Mahadev, Venketasubramanian, Narayanaswamy   +3 more
openaire   +1 more source

Randomised, double-blind, placebo-controlled study investigating Safety and efficAcy of MLC901 in post-traUmatic bRAin Injury: the SAMURAI study protocol. [PDF]

BMJ Open, 2022
Pilipenko P, Pilipenko P, Ivanova AA, Kotsiubinskaya YV, Feigin V, Majdan M, Grigoryeva VN, Khrulev AY.   +7 more
europepmc   +1 more source

Clinical Study The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients

, 2020
Aim. We aimed to assess the efficacy of MLC601 on functional recovery in patients given MLC601 after an ischemic stroke. Methods. This is a retrospective cohort study comparing poststroke patients given open-label MLC601 (n = 30; 9 female) for three ...
Alejandro C Baroque Ii, Johnny K Lokin, Jose C Navarro, Mark C Molina   +3 more
core